School of Nursing, Faculty of Health, Queensland University of Technology, Brisbane, Australia; Child Health Research Centre, The University of Queensland, Brisbane, Australia; Paediatric Intensive Care, Queensland Children's Hospital, Brisbane, Australia.
School of Nursing, Faculty of Health, Queensland University of Technology, Brisbane, Australia; Neonatal Intensive Care Unit, Mater Mother's Hospital, Brisbane, Australia.
Aust Crit Care. 2024 Nov;37(6):903-911. doi: 10.1016/j.aucc.2024.05.001. Epub 2024 Jun 11.
The development of new morbidities has become increasingly identified in paediatric critical care medicine. To date, there has been limited research of long-term outcomes following paediatric critical illness in Australia.
The objective of this study was to quantify neurodevelopmental impairments in children following paediatric intensive care unit (PICU) discharge and their association with health-related quality of life (HRQoL).
A single-centre ambidirectional cohort study at an Australian hospital. Parents of children admitted to the PICU between 2015 and 2017 were invited to participate. Neurodevelopmental outcome and HRQoL was prospectively evaluated, using the Ages and Stages Questionnaire (<5 years), Strengths and Difficulties Questionnaire (≥5 years), and Pediatric Quality of Life Inventory™, respectively.
A total of 230 parents of critically ill children participated. Children were 1.9 years old (median, interquartile range [IQR]: 0.2, 7.5), male (59.6%), and ventilated (49.1%) at PICU admission. The median time to follow-up was 24.4 months (IQR: 16.3, 36.7). Parent respondents were more likely to be female (85.5%), White (88.3%), and partnered (81.1%). The incidence of overall neurodevelopmental impairment was 30% (33% in children aged <5 years; 24% in children aged ≥5 years). The incidence of poor HRQoL was 37.9%. History of developmental delay was independently associated with overall neurodevelopmental impairment (adjusted odds ratio [aOR]: 4.21, 95% confidence interval: 2.05, 8.63) and poor HRQoL (aOR: 7.29, 95% confidence interval: 3.26, 16.27). Two or more PICU admissions (aOR: 4.10, IQR: 1.82, 9.26) was also associated with poor HRQoL.
This is the first contemporary view of PICU long-term outcomes conducted in Australia and significantly informs ongoing research in this area. Approximately one-third of PICU survivors demonstrate neurodevelopmental impairment and reduced quality of life. Multiple domains of post-intensive care syndrome-paediatrics must be considered to have a comprehensive understanding of child outcomes. Assessment of baseline/premorbid functioning is also essential in order to understand the true impact of illness and PICU admission.
新发病已在儿科重症监护医学中日益得到确认。迄今为止,澳大利亚对儿科危重病后的长期结果的研究有限。
本研究的目的是量化儿科重症监护病房(PICU)出院后儿童的神经发育障碍及其与健康相关生活质量(HRQoL)的关系。
这是澳大利亚一家医院进行的单中心双向队列研究。邀请了 2015 年至 2017 年期间入住 PICU 的儿童的父母参加。使用年龄和阶段问卷(<5 岁)、优势与困难问卷(≥5 岁)和儿科生活质量量表分别前瞻性评估神经发育结果和 HRQoL。
共有 230 名重病儿童的父母参加了研究。儿童 PICU 入院时年龄为 1.9 岁(中位数,四分位距[IQR]:0.2,7.5),男性(59.6%),需要通气(49.1%)。中位随访时间为 24.4 个月(IQR:16.3,36.7)。父母受访者更有可能是女性(85.5%)、白人(88.3%)和已婚(81.1%)。整体神经发育障碍的发生率为 30%(<5 岁的儿童为 33%;≥5 岁的儿童为 24%)。HRQoL 不良的发生率为 37.9%。发育迟缓史与整体神经发育障碍(调整优势比[aOR]:4.21,95%置信区间:2.05,8.63)和 HRQoL 不良(aOR:7.29,95%置信区间:3.26,16.27)独立相关。两次或更多次 PICU 入院(aOR:4.10,IQR:1.82,9.26)也与 HRQoL 不良相关。
这是澳大利亚进行的首例关于 PICU 长期结果的当代研究,为该领域的持续研究提供了重要信息。大约三分之一的 PICU 幸存者存在神经发育障碍和生活质量下降。必须考虑多种 ICU 后综合征儿科领域,才能全面了解儿童的结局。评估基线/发病前的功能也很重要,以便了解疾病和 PICU 入院的真正影响。